Global Epigenetics (VLA, WBA, NBA, RTA, Rotary-Wing Aircraft) Market - Forecast to 2019
DUBLIN, Oct 24, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Epigenetics Market by Product , Research Area & by End User - Global Forecast to 2019" report to their offering.
http://photos.prnewswire.com/prnh/20130307/600769
In this report, the global epigenetics market is segmented on the basis of products, research areas, and end users. The product segments of the epigenetics market included in this report are enzymes, instruments & consumables, kits, and reagents. The subsegments of the enzymes product segment are DNA-modifying enzymes (DNA ligases, DNA polymerases and other DNA-modifying enzymes); protein-modifying enzymes (acetylases, methyltransferases and other protein-modifying enzymes); and RNA-modifying enzymes (reverse transcriptases, RNA ligases, and other RNA-modifying enzymes).
The subsegments of the instruments & consumables product segment are mass spectrometers; next-generation sequencers; qPCRs; sonicators; and other epigenetics instruments & consumables. The subsegments of the kits product segment are bisulfite conversion kits; ChIP-seq kits; RNA sequencing kits; whole genome amplification kits; 5-hmC & 5-mC analysis kits; and other epigenetics kits. The subsegments of the reagents product segment are antibodies; buffers; histones; magnetic beads; primers; and other epigenetics reagents.
Epigenetics has applications in a large number of research areas. On the basis of research areas, the report is segmented into developmental biology, drug discovery, oncology, and other epigenetics research areas. On the basis of end users, the global epigenetics market report is segmented into academic research institutes, biotechnology and pharmaceutical companies, and contract research organizations. The geographic segments included in this report are Asia, Europe, North America, and Rest of the World.
The key driver for this market is growth in cancer prevalence. The rising incidence of this disease has prompted increased research interest and funding for research. Furthermore, as epigenetics has shown potential for the development of new therapeutic products for diseases like cancer, partnerships between biotechnology and pharmaceutical companies for the development of epigenetics-based therapeutics products have increased, leading to intensified R&D activities in this field; all factors that will aid the growth of the global epigenetics market.
In this report, a combination of bottom-up and top-down approaches were used to calculate market sizes and growth rates. Secondary information was used to identify overall revenue, geographic reach, and product portfolios of market players. Estimates of their epigenetics segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine percentage shares of each subsegment and the relative differences in the growth rates.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Insights
7 Epigenetics Market, By Product
8 Epigenetics Market, By Research Areas
9 Market, By End User
10 Geographic Analysis
11 Competitive Landscape
12 Company Profiles
13 Appendix
Companies Mentioned:
- Abcam
- Active Motif
- Diagenode
- Illumina
- Merck
- New England Biolabs
- Qiagen
- Sigma-Aldrich Corporation
- Thermo Fisher Scientific
- Zymo Research
For more information visit http://www.researchandmarkets.com/research/3jbn26/epigenetics
Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net
Share this article